🇺🇸 FDA
Patent

US 9309232

Synthesis of novel inhibitors of isoprenoid biosynthesis

granted A61KA61K31/4164A61K31/4174

Quick answer

US patent 9309232 (Synthesis of novel inhibitors of isoprenoid biosynthesis) held by Beryllium Discovery Corp. expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beryllium Discovery Corp.
Grant date
Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4164, A61K31/4174, A61K31/4178, A61K31/506